NLRC4 and metabolic dysfunction-associated steatohepatitis: In addition, the omega‐3 fatty acid (ω‐3 FA) docosahexaenoic acid (DHA), which has a protective effect against NASH, has recently been shown to alleviate the palmitate (PA)‐induced inflammatory agents and lipid accumulation via suppression of human NLRC4 expression and inhibition of caspase 1 and IL‐1β cleavage.